Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.72 |
| ▸ | CA12 | O43570 | 1/20 | 0.67 |
| ▸ | CA1 | P00915 | 1/20 | 0.67 |
| ▸ | CA2 | P00918 | 1/20 | 0.67 |
| ▸ | CA4 | P22748 | 1/20 | 0.67 |
| ▸ | CA6 | P23280 | 1/20 | 0.67 |
| ▸ | CA7 | P43166 | 1/20 | 0.67 |
| ▸ | TPMT | P51580 | 1/20 | 0.67 |
| ▸ | CA9 | Q16790 | 1/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.67 |
| ▸ | THRA | P10827 | 1/20 | 0.66 |
| ▸ | THRB | P10828 | 1/20 | 0.66 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.60 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.58 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18682279 | 0.98 | PLA2G4B (0.74) | TSHRPLA2G4BCA12CA1CA2 | |
| SCHEMBL29171441 | 0.98 | PLA2G4B (0.74) | TSHRPLA2G4BCA12CA1CA2 | |
| SCHEMBL29171434 | 0.98 | PLA2G4B (0.74) | TSHRPLA2G4BCA12CA1CA2 | |
| SCHEMBL7273205 | 0.98 | PLA2G4B (0.74) | TSHRPLA2G4BCA12CA1CA2 | |
| SCHEMBL16077692 | 0.98 | PLA2G4B (0.74) | TSHRPLA2G4BCA12CA1CA2 | |
| SCHEMBL9307551 | 0.98 | PLA2G4B (0.74) | TSHRPLA2G4BCA12CA1CA2 | |
| SCHEMBL2312195 | 0.98 | PLA2G4B (0.74) | TSHRPLA2G4BCA12CA1CA2 | |
| SCHEMBL29171422 | 0.98 | PLA2G4B (0.74) | TSHRPLA2G4BCA12CA1CA2 | |
| SCHEMBL1750327 | 0.97 | TSHR (0.74) | TSHRPLA2G4BCA12CA1CA2 | |
| Ethylene Glycol SCHEMBL11237315 | 0.94 | PLA2G4B (0.70) | TSHRPLA2G4BCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107011924-B | Photoalignment materials with side substitution | 罗利克有限公司 | 2021-06-01 | — | — | CN | disclosed |
| US-10738242-B2 | Compound, cured product, polymer, photo-alignment film, optically anisotropic body and liquid crystal display element | DIC CORPORATION (JP) | 2020-08-11 | — | — | US | disclosed |
| EP-2534191-B1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC TECH AG (CH) | 2020-04-15 | — | — | EP | disclosed |
| US-9939555-B2 | Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured product thereof | DIC CORPORATION (JP) | 2018-04-10 | — | — | US | disclosed |
| US-9708535-B2 | Liquid crystal alignment layer | DIC CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20170088777-A1 | LIQUID CRYSTAL ALIGNMENT LAYER | DIC CORPORATION (JP) | 2017-03-30 | — | — | US | disclosed |
| EP-2534191-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | Rolic AG (CH) | 2012-12-19 | — | — | EP | disclosed |
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC AG (CH) | 2012-12-13 | — | — | US | disclosed |
| WO-2011098461-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC AG (CH) | 2011-08-18 | — | — | WO | disclosed |
| US-5459134-A | Leukotriene antagonists; phospholipase, 5-alpha-reductase, and aldose reductase inhibitors | ONO PHARMACEUTICAL CO., LTD. (JP) | 1995-10-17 | — | — | US | disclosed |
| US-5446058-A | Leukotriene antagonists, 5-alpha-reductase inhibitors | ONO PHARMACEUTICAL CO., LTD. (JP) | 1995-08-29 | — | — | US | disclosed |
| EP-0173516-B1 | (Fused)benz(thio)amides | ONO PHARMACEUTICAL CO (JP) | 1993-12-01 | — | — | EP | disclosed |
| US-4939141-A | (Fused) benz (thio) amides and pharmaceutical compositions, thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 1990-07-03 | — | — | US | disclosed |
| US-4847275-A | ENZYME INHIBITOR, LEUKOTRIENE ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 1989-07-11 | — | — | US | disclosed |
| US-4780469-A | (Fused) benz(thio)amides and pharmaceutical use | ONO PHARMACEUTICAL CO., LTD. (JP) | 1988-10-25 | — | — | US | disclosed |
| EP-0173516-A2 | (Fused)benz(thio)amides | ONO PHARMACEUTICAL CO., LTD. (JP) | 1986-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10738242-B2 | Compound, cured product, polymer, photo-alignment film, optically anisotropic body and liquid crystal display element | PYM1, ZYX, CRY1 | TSHR 4185/4885PLA2G4B 1428/4885CA12 1572/4885 |
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | LATS1, LATS2, LCP1 | TSHR 4705/4885PLA2G4B 1237/4885CA12 3886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.